Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by eng41on Mar 07, 2022 4:08pm
340 Views
Post# 34492392

Email

Email Hi Rick, Nothing has changed in our business. We will press release when we submit the FDA EUA. Thanks Rob Rob Fia, CFA, CEO Therma Bright Inc. www.thermabright.com This e-mail, and any attachments, is privileged and may contain confidential information intended only for the person(s) named above. If you receive this e-mail in error, please notify the addressee immediately by e-mail or phone and permanently delete the e-mail and any attachments. F Sent: March 7, 2022 11:20 AM To: Rob Fia Subject: FDA approval I have been holding a large position in thrm for more than a year. Presently at a loss. Based on prior communication from the company I expected FDA before Christmas and then shortly after. Based on the last news release 3 weeks ago and the 6 million investment I thought we were almost there. Please help me understand the delay on FDA submission or at what point we are in the process Thanks Rick Concerned shareholder Sent from Rogers Yahoo Mail on Android Show less
<< Previous
Bullboard Posts
Next >>